We just received data on a new analyst forecast for $MEDP. Michael Cherny from Leerink Partners set a price target of 485.0 for MEDP.
To track analyst ratings and price targets for $MEDP, check out Quiver Quantitative's $MEDP forecast page.
Should you buy $MEDP?
Some analysts are better than others. To view the past performance of Leerink Partners, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$MEDP Price Targets
Multiple analysts have issued price targets for $MEDP recently. We have seen 7 analysts offer price targets for $MEDP in the last 6 months, with a median target of $485.0.
Here are some recent targets:
- Michael Cherny from Leerink Partners set a target price of $485.0 on 02/11/2026
- Luke Sergott from Barclays set a target price of $525.0 on 12/15/2025
- Sean Dodge from BMO Capital set a target price of $600.0 on 11/13/2025
- Ann Hynes from Mizuho set a target price of $655.0 on 10/24/2025
- Charles Rhyee from TD Cowen set a target price of $462.0 on 10/24/2025
- David Windley from Jefferies set a target price of $450.0 on 09/09/2025
- Jamie Clark from Rothschild & Co set a target price of $474.0 on 09/03/2025
$MEDP Insider Trading Activity
$MEDP insiders have traded $MEDP stock on the open market 30 times in the past 6 months. Of those trades, 0 have been purchases and 30 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by insiders over the last 6 months:
- AUGUST J. TROENDLE (CEO) has made 0 purchases and 18 sales selling 316,431 shares for an estimated $185,688,639.
- SUSAN E BURWIG (Exec. VP, Operations) has made 0 purchases and 4 sales selling 50,000 shares for an estimated $29,083,020.
- JESSE J GEIGER (President) has made 0 purchases and 3 sales selling 44,531 shares for an estimated $26,671,392.
- STEPHEN P EWALD (General Counsel & Corp. Secy.) sold 15,230 shares for an estimated $9,120,485
- ROBERT O. KRAFT sold 6,472 shares for an estimated $3,830,453
- FRED B JR DAVENPORT sold 5,972 shares for an estimated $3,474,987
- KEVIN M. BRADY (CFO & Treasurer) sold 3,000 shares for an estimated $1,771,050
- CORNELIUS P. III MCCARTHY sold 1,662 shares for an estimated $772,896
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$MEDP Revenue
$MEDP had revenues of $708.5M in Q4 2025. This is an increase of 32.03% from the same period in the prior year.
You can track MEDP financials on Quiver Quantitative's MEDP stock page.
$MEDP Congressional Stock Trading
Members of Congress have traded $MEDP stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $MEDP stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 1 purchase worth up to $15,000 on 01/29 and 1 sale worth up to $15,000 on 01/16.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 10/09.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$MEDP Hedge Fund Activity
We have seen 368 institutional investors add shares of $MEDP stock to their portfolio, and 342 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AQR CAPITAL MANAGEMENT LLC added 404,226 shares (+65.1%) to their portfolio in Q3 2025, for an estimated $207,836,840
- EPOCH INVESTMENT PARTNERS, INC. removed 319,530 shares (-71.8%) from their portfolio in Q3 2025, for an estimated $164,289,544
- D. E. SHAW & CO., INC. added 256,577 shares (+74.7%) to their portfolio in Q3 2025, for an estimated $131,921,630
- JANE STREET GROUP, LLC removed 256,513 shares (-82.3%) from their portfolio in Q3 2025, for an estimated $131,888,724
- MAWER INVESTMENT MANAGEMENT LTD. removed 239,472 shares (-37.0%) from their portfolio in Q4 2025, for an estimated $134,499,448
- MILLENNIUM MANAGEMENT LLC removed 228,319 shares (-66.2%) from their portfolio in Q3 2025, for an estimated $117,392,497
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 211,411 shares (+205.8%) to their portfolio in Q3 2025, for an estimated $108,699,079
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
